`
`
`
`
`
`Steve H. Patience
`State Bar No. 009537
`SKOUSEN, GULBRANDSEN
`& PATIENCE, PLC
`414 East Southern Avenue
`Mesa, AZ 85204
`Telephone: 480-833-8800
`Email: shp@sgplaw.com
`Attorneys for Plaintiffs
`
`
`
`UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF ARIZONA
`
`
`
`/ Case Number:
`
`
`MICHAEL JANISKY and
`/
`
`
`SUSAN JANISKY,
`
`/
`
`
`
`
`
`
`/
`
`
`
` Plaintiffs,
`/
`
`
`
`
`
`
` COMPLAINT AND
`/
`v.
`
`
`
`
`
`/ DEMAND FOR JURY TRIAL
`
`
`
`
`
`
`/
`ZIMMER US, INC.,
`
`
`/
`d/b/a Zimmer Biomet,
`
`
`/
`ZIMMER, INC., and
`
`
`ZIMMER BIOMET HOLDINGS, INC., /
`f/k/a ZIMMER HOLDINGS, INC.
`
`/
`
`
`
`
`
`
`/
`
`
`
` Defendants.
`/
`____________________________________/
`
`
`COMPLAINT AND JURY DEMAND
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`
`
`COME NOW THE PLAINTIFFS, Michael Janisky and Susan Janisky (hereinafter
`
`“Plaintiffs”), by and through their counsel, Steve H. Patience, Skousen, Gulbrandsen & Patience,
`
`PLC, and file their Complaint for damages and Jury Demand against Defendants, Zimmer US,
`
`Inc., d/b/a Zimmer Biomet, Zimmer, Inc., and Zimmer Biomet Holdings, Inc., formerally known
`
`as Zimmer Holdings, Inc., and allege and state the following:
`
`
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`
`
`
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 2 of 23
`
`
`
`The Parties
`
`1.
`
`Plaintiff Michael Janisky at all times relevant hereto was and is a citizen of the State
`
`of Arizona, residing in Camp Verde, Yavapai County, Arizona.
`
`2.
`
`Plaintiff Susan Janisky at all times relevant hereto was and is a citizen of the State
`
`of Arizona, residing in Camp Verde, Yavapai County, Arizona.
`
`3.
`
`At all times relevant hereto Plaintiff Michael Janisky and Plaintiff Susan Janisky
`
`were and are married to each other.
`
`4.
`
`Zimmer US, Inc., is a Delaware Corporation, with its principle place of business
`
`located in Warsaw, Indiana. As such Zimmer US, Inc., is a citizen of the State of Delaware and/or
`
`the State of Indiana.
`
`5.
`
`Zimmer US, Inc., is registered with the Arizona Secretary of State as doing business
`
`as Zimmer Biomet in the State of Arizona.
`
`6.
`
`Zimmer, Inc., is a Delaware Corporation, with its principle place of business
`
`located in Warsaw, Indiana. As such Zimmer, Inc., is a citizen of the State of Delaware and/or
`
`the State of Indiana.
`
`7.
`
`Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is a
`
`Delaware Corporation, with its principle place of business in the United States located in Warsaw,
`
`Indiana. As such Zimmer Biomet Holdings, Inc., is a citizen of the State of Delaware and/or the
`
`State of Indiana.
`
`8.
`
`At all relevant times, Zimmer US, Inc. was a wholly owned subsidiary of Defendant
`
`Zimmer Biomet Holdings, Inc.
`
`9.
`
`At all relevant times, Zimmer, Inc., was a wholly owned subsidiary of Defendant
`
`Zimmer Biomet Holdings, Inc.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`- 2 -
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 3 of 23
`
`10. Zimmer GmbH is not a named party to this civil action but is a predecessor,
`
`affiliate, alter ego, or alternative name, of one or more or all of the Zimmer Defendants named as
`
`parties to this action.
`
`11. Defendant, Zimmer, Inc., designed, manufactured, labeled, marketed, supplied,
`
`distributed and/or sold the subject Durom Cup and the related implant system to physicians,
`
`hospitals, and clinics to be surgically implanted in patients in the State of Arizona.
`
`12. Defendant, Zimmer Biomet Holdings, Inc., designed, manufactured, labeled,
`
`marketed, supplied, distributed and/or sold the subject Durom Cup and the related implant system
`
`to physicians, hospitals, and clinics to be surgically implanted in patients in the State of Arizona.
`
`13. Defendant, Zimmer US, Inc., designed, manufactured, labeled, marketed, supplied,
`
`distributed, and/or sold the subject Durom Cup and the related implant system to physicians,
`
`hospitals, and clinics to be surgically implanted in patients in the State of Arizona.
`
`Jurisdiction & Venue
`
`14.
`
`This Court has subject matter jurisdiction over this civil action pursuant to 28
`
`U.S.C. §1332(a), as the parties are citizens of different states, and the amount in controversy
`
`exceeds the sum or value of $75,000, exclusive of interest and costs.
`
`15.
`
`At all relevant times, Zimmer US, Inc., did business in the State of Arizona, or had
`
`substantial contacts with the State of Arizona.
`
`16.
`
`At all relevant times, Zimmer, Inc., did business in the State of Arizona, or had
`
`substantial contacts with the State of Arizona.
`
`17.
`
`At all relevant times, Zimmer Biomet Holdings, Inc., did business in the State of
`
`Arizona, or had substantial contacts with the State of Arizona.
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`- 3 -
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 4 of 23
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`18.
`
`Said Defendants actions stated herein and the relevant and material events,
`
`incidents, and actions, involving the parties to this action, including the incident which resulted
`
`in the damages sustained by Plaintiffs, took place within the State of Arizona.
`
`19.
`
`The Court has personal jurisdiction over the Defendants as Plaintiffs’ claims arise
`
`out of Defendants’ commission of tortious acts or the transaction of business and within the State
`
`of Arizona.
`
`20.
`
`Venue is proper in this Court pursuant to 28 U.S.C. §1391(a) and (c).
`
`General Allegations
`The Zimmer Durom® Cup
`
`21.
`
`On or about December 19, 2005, Zimmer GmbH sent to the United States Food and
`
`Drug Administration [FDA] what is known as a Section 510(k) premarket notification of intent
`
`12
`
`to market a device that Zimmer GmbH identified by the Trade/Device Name as the Durom®
`
`Acetabular Component and Metasul® LDHTM Large Diameter Heads.
`
`22.
`
`On March 16, 2006 the FDA issues its clearance for Zimmer GmbH to distribute in
`
`the United States the Durom® Acetabular Component and Metasul® LDHTM Large Diameter
`
`Heads.
`
`23.
`
`The FDA clearance for Zimmer GmbH to distribute in the United States the
`
`Durom® Acetabular Component and Metasul® LDHTM Large Diameter Heads was given the
`
`designation of 510(k) Number K053536.
`
`24.
`
`The Durom® Acetabular component that was cleared for distribution in the United
`
`States as 510(k) Number K053536 came to be generally known as the Zimmer “Durom® Cup”.
`
`25.
`
`The Durom® Acetabular component is a metal monoblock CoCrMo alloy [cobalt
`
`chromium molybdenum] cup with a coating of titanium plasma spray. It was available in sizes
`
`from 44 to 66 mm, and was intended for press-fit fixation in the acetabulum.
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`- 4 -
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 5 of 23
`
`26.
`
`The Metasul® LDHTM femoral heads are made of CoCrMo alloy and were available
`
`in diameters ranging from 38 to 60mm. They were modular in design and were for use with four
`
`head/neck length adaptors (-4 to +8mm), also manufactured from CoCrMo alloy. The femoral
`
`heads and neck adapters were compatible with 12/14 taper femoral stems.
`
`27.
`
`The Metasul® LDHTM large diameter head system consists of large diameter
`
`femoral heads, Durom® acetabular components and neck adapters for neck length variation.
`
`[Hereinafter this combination of devices will at times be referred to as the “Durom® Cup hip
`
`system.”]
`
`28.
`
`The Metasul® LDHTM large diameter head system, consisting of large diameter
`
`femoral heads made of a CoCrMo alloy, combined with Durom® acetabular component also made
`
`of a CoCrMo alloy, is what is generally known in the field of orthopaedic surgery as a Metal-on-
`
`Metal bearing surface artificial hip.
`
`29.
`
`The Zimmer Durom® Cup was a medical device intended to be surgically implanted
`
`in patients as the acetabular component of a hip replacement surgery.
`
`30.
`
`The Zimmer Durom® Cup hip system was a combination of various medical
`
`devices intended to be surgically implanted in patients as total hip arthroplasty, the complete
`
`replacement of the hip joint.
`
`31.
`
`One or more, or all, of the Zimmer Defendants, or their predecessors in interest,
`
`designed, manufactured, marketed, distributed and sold in the United States, including in the state
`
`of Arizona, the Metasul® LDHTM large diameter head system including the Durom® acetabular
`
`component, a/k/a the Durom® Cup, and neck adaptors.
`
`32.
`
`The Durom® Cup has proven to be a device that is defective in its design and in its
`
`manufacture.
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`- 5 -
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 6 of 23
`
`33.
`
`The Durom® Cup hip system has proven to be a device that is defective in its design
`
`and in its manufacture.
`
`34.
`
`On September 26, 2008, the FDA issued a Class 2 Recall of the Zimmer Durom
`
`Cup.
`
`35.
`
`Zimmer stated the reason for the Class 2 Recall was because the instructions for
`
`use and the surgical technique instructions were determined to be inadequate.
`
`36.
`
`The FDA’s stated cause for the Class 2 Recall was “MISBRANDING: Labeling
`
`False and Misleading”.
`
`37.
`
`The implantation of the Zimmer Durom® Cup, and the Durom® Cup hip system, in
`
`patients has resulted in premature failure, metal poisoning and the need for surgery for the removal
`
`and replacement (revision) of the Durom® Cup and other related artificial hip devices used with
`
`it.
`
`38.
`
`The Durom® Cup, and the Durom® Cup hip system, designed, manufactured,
`
`labeled, distributed, sold and/or supplied by defendants were placed into the stream of commerce
`
`in a defective and unreasonably dangerous condition as designed, taking into account the utility
`
`of the product and the risk involved in its use.
`
`39.
`
`Zimmer’s Durom® Cup, and the Durom® Cup hip system, designed, manufactured,
`
`labeled, marketed, distributed, sold and/or supplied by Defendants was defective and
`
`unreasonably dangerous due to its marketing and inadequate warnings or instructions needed for
`
`the reasonably safe use of the device, independently and when coupled with its aggressive
`
`marketing campaign.
`
`40.
`
`Zimmer failed to recognize the deficiencies of various components of the Durom®
`
`Cup hip system due to poor and inadequate quality assurance procedures, including failure of
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`- 6 -
`
`
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 7 of 23
`
`Zimmer to implement appropriate physical, manual, x-ray, microscopic and other inspections of
`
`the Durom® Cup.
`
`41.
`
`During the time Zimmer manufactured the various components of the Durom® Cup
`
`hip system, inadequate design, manufacturing and labeling processes led to material flaws in the
`
`quality systems at its manufacturing facilities.
`
`42.
`
`During the course of designing, manufacturing and labeling the various
`
`components of the Durom® Cup hip system, Zimmer failed in several ways, including, without
`
`limitation, by:
`
`a. failing to conduct adequate mechanical testing on components, subassemblies
`and/or finished Durom® Cup and/or the related components of the Durom® Cup
`hip system;
`
`b. failing to test an adequate number of sample devices on an ongoing basis;
`
`c. failing to take adequate steps to specifically identify modes with clarity and
`suggest methods to monitor, avoid, and/or prevent further failure of the Durom®
`Cup and/or the related components of the Durom® Cup hip system;
`
`d. failing to identify and/or not the significance of any testing that resulted in
`failures of the Durom® Cup and/or the related components of the Durom® Cup
`hip system;
`
`e. failing to take corrective actions to eliminate or minimize further failures of the
`Durom® Cup and/or the related components of the Durom® Cup hip system;
`
`f. failing to adequately explain performance specifications for the components,
`subassemblies, and finished Durom® Cup and/or the related finished
`components of the Durom® Cup hip system;
`
`g. failing to adequately explain or justify all test conditions and acceptance criteria
`for the Durom® Cup and/or the related components of the Durom® Cup hip
`system;
`
`h. failing to perform adequate testing in an environment that adequately simulated
`in vivo conditions; and, by,
`
`failing to perform adequate assurance testing before and after sterilization.
`
`i.
`
`
`
`- 7 -
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 8 of 23
`
`
`
`
`
`j. Failing to provide adequate warnings for reasonable safe use.
`
`Plaintiff Michael Janisky’s Durom® Cup
`
`43.
`
`Prior to 2007 Plaintiff Michael Janisky suffered from bilateral hip osteoarthritis of
`
`his hip joints.
`
`44.
`
`Following a left total hip replacement in 2007, Plaintiff Michael Janisky started
`
`increasing his activity. With the increased activity, Mr. Janisky’s right hip started bothering him.
`
`He had discomfort along with significant arthritic changes on x-ray. He had been advised that he
`
`was a candidate for and upon medical advice should submit to right total hip arthroplasty
`
`replacement surgery to relieve his hip pain, regain his quality of life, and maintain his lifestyle.
`
`45.
`
`In consultation with Plaintiff Michael Janisky’s orthopedic surgeon, Theodore P.
`
`Firestone, M.D., Dr. Firestone proposed to Plaintiff to implant in him the Zimmer Metasul® LDH
`
`54 mm head, in conjunction with the 60 mm Metasul Durom® Acetabular Component.
`
`46.
`
`Literature and marketing information published by Zimmer included the following
`
`statements and information:
`
`a. “The combination of a Metasul LDH and, the Durom acetabular component and
`one of Zimmer’s clinically proven stems provides a hip system which retains
`the key aspects of Durability and Range of Motion.”
`
`b. “This product is particularly suited to patients who are at risk of requiring
`multiple hip replacements over their lifetimes since it preserves more of the
`patient’s healthy bone stock. A primary objective of this system is to allow the
`patient to return to an active lifestyle.”
`
`
`c. “A Metasul LDH large diameter head, used in conjunction with the Durom®
`Acetabular Component is designed to be a solution for active patients.”
`
`
`d. “The combination of a Metasul LDH large diameter head and a Durom
`acetabular component makes it possible to increase the maximum range of
`motion without sacrificing prosthesis stability.”
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`
`
`25
`
`
`
`- 8 -
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 9 of 23
`
`47.
`
`Based on the information provided by Dr. Firestone, Plaintiff Michael Janisky made
`
`the decision to have the Zimmer modular system implanted, including the Metasul LDH head and
`
`a Durom acetabular component, instead of any other artificial hip devices or systems that were
`
`available on the market.
`
`48.
`
`On November 26, 2008, Dr. Firestone performed a total hip arthroplasty on Plaintiff
`
`Michael Janisky’s right hip at Scottsdale Healthcare Shea Hospital in Scottsdale, Arizona.
`
`Plaintiff Michael Janisky was 61years of age.
`
`49.
`
`The Zimmer Metasul® LDHTM head and other Zimmer artificial hip devices
`
`implanted in Plaintiff Michael Janisky’s right hip on November 26, 2008 included, but were not
`
`limited to, the following:
`
`a. Metasul® Durom® Acetabular Component
`Code T
`Uncemented 60/54
`REF: 01.00214.160; LOT: 2409336
`
`b. Metasul® LDHTM Head
`54 Code T Taper 15/20
`REF: 01.00181.540; LOT: 2428777
`
`c. Zimmer® Fitmore Hip Stem uncemented B / 6. Taper12/14
`REF: 01.00551.206; LOT: 2374123DL
`
`d. Metasul® LDHTM Head Adaptor
`REF: 01.00185.146; LOT: 2429329
`
`
`50.
`
`On September 26, 2008, approximately two months before Plaintiff Michael
`
`Janisky was implanted with his Zimmer Durom cup, the FDA issued a Class 2 Recall of the
`
`Durom Cup.
`
`51.
`
`Zimmer stated the reason for the Class 2 Recall was because the instructions for
`
`use and surgical technique instructions were inadequate.
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`- 9 -
`
`
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 10 of 23
`
`52.
`
`The FDA stated the cause for the Class 2 Recall was “MISBRANDING: Labeling
`
`False and Misleading”.
`
`Plaintiff Michael Janisky’s Durom® Cup Failure
`
`53.
`
`Over time the right Zimmer Metasul® - Durom® Cup artificial hip of Plaintiff
`
`Michael Janisky failed.
`
`54.
`
`The progressive failure of the right Zimmer Metasul® - Durom® Cup artificial hip
`
`of Plaintiff Michael Janisky caused him pain, suffering, disability and physical impairment.
`
`55.
`
`In mid-December of 2019 Plaintiff Michael Janisky, first sought medical advice
`
`concerning pain he had recently begun to experience in his right hip. At that time he was first
`
`told that he may be in need of a revision surgery for the removal and the replacement of his right
`
`Zimmer Metasul® - Durom® Cup artificial hip.
`
`56.
`
`On January 16, 2019, Dr. Firestone performed hip revision surgery to replace the
`
`failed right Zimmer Metasul® - Durom® Cup artificial hip of Plaintiff Michael Janisky.
`
`57.
`
`The operative note for the revision of the right hip includes the following
`
`observations by Dr. Firestone:
`
`… I made a capsulectomy there with the electrocautery. Underneath, there
`was a large creamy effusion. The effusion was the consistency of pea soup.
`This was aspirated and sent for culture. It was consistent with pseudotumor
`and significant bone destruction. A complete excision of all the very
`thickened granuloma was then undertaken. This probably took about 45
`minutes in itself, excising all the thickened scar tissue, which was in the
`form of caseous necrosis. This was, unfortunately, a significant amount of
`the acetabular bone as well as the proximal femur, which had undergone
`significant resorption. At this point, it was evident that there was significant
`corrosion at the femoral head of the well-fixed short stem. It was still well
`fixed. I disimpacted the large cobalt chrome head, first while it was in the
`socket, and then externally rotated the stem and removed the femoral head.
`This allowed for further acetabular exposure and I did a further
`debridement. . . . I was able to easily remove the Durom shell, which
`measured 60 mm. There was only fibrous fixation at best.
`
`- 10 -
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 11 of 23
`
`
`
`Plaintiffs’ Damages
`
`58.
`
`As a direct and proximate result of the said defects of the Durom® Cup, and the
`
`conduct of the Defendants, the Plaintiff Michael Janisky has suffered personal injuries.
`
`59.
`
`As a direct and proximate result of these defective implants, and the revision
`
`surgery, Plaintiff Michael Janisky is at an increased risk for having future revision surgeries.
`
`60.
`
`As a direct and proximate result of these defective implants, and the revision
`
`surgery, Plaintiff Michael Janisky has suffered personal injury, and has endured pain, suffering,
`
`discomfort, disability, illness, physical impairment in the past and will continue to suffer and
`
`endure these injuries and damages in the future.
`
`61.
`
`As a direct and proximate result of these defective implants, Plaintiff Michael
`
`Janisky has suffered disability, physical impairment, and illnesses that are the direct and
`
`proximate result of the defective Zimmer Metasul® - Durom® Cup artificial hips that had been
`
`implanted in him.
`
`62.
`
`As a direct and proximate result of these defective implants, and the revision
`
`surgery, Plaintiff Michael Janisky has incurred reasonable and necessary medical care and
`
`expenses in excess of $75,000 in the past and will continue to incur medical expenses in the future.
`
`63.
`
`As a direct and proximate result of these defective implants, Plaintiff Michael
`
`Janisky also suffered mental anguish, anxiety, and emotional distress as one would be expected
`
`to have suffered and will reasonably probably suffer in the future due to his medical condition
`
`caused by the defective and failed Zimmer Metasul® - Durom® Cup artificial hips that had been
`
`implanted in him, and the revision surgery that he has endured.
`
`64.
`
`As a direct and proximate result of these defective implants, Plaintiff Susan Janisky
`
`has suffered the loss of the consortium of her husband Michael Janisky.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`- 11 -
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 12 of 23
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`65.
`
`As a direct and proximate result of the actions of the Defendants, Plaintiffs suffered
`
`severe and permanent physical injury, loss of enjoyment of life and other damages as set forth
`
`elsewhere in this Complaint.
`
`FIRST CAUSE OF ACTION
`STRICT PRODUCT LIABILITY
`
`66.
`
`The allegations contained in all prior paragraphs are incorporated herein by
`
`reference.
`
`67.
`
`In and prior to November 2008, Defendants were engaged in the business of
`
`designing, manufacturing, marketing, distributing, labeling, and selling orthopedic hip implants
`
`and did design, manufacture, distribute, market, label and sell the artificial hip devices implanted
`
`in Plaintiff Michael Janisky on November 26, 2008.
`
`68.
`
`Defendants had a duty to place into the stream of commerce, design, manufacture,
`
`distribute, market, promote, label and sell the Durom® Cup hip system so that it was neither
`
`defective or unreasonably dangerous when put to the use for which it was designed, manufactured,
`
`distributed, marketed, and sold.
`
`69.
`
`Defendants did in fact design, manufacture, label, sell, distribute, supply, and/or
`
`promote the Durom® Cup to Plaintiff Michael Janisky and his implanting physician, Theodore P.
`
`Firestone, M.D.
`
`70.
`
`Defendants expected the Durom® Cup hip system they designed and were selling,
`
`distributing, supplying, manufacturing, labeling, marketing and/or promoting to reach, and which
`
`did in fact reach, implanting physicians and consumers in the State of Arizona, including Plaintiff
`
`and his implanting physician, without substantial change in its condition.
`
`71.
`
`The Durom® Cup hip system implanted in the Plaintiff Michael Janisky was
`
`designed, manufactured, labeled, marketed, distributed, sold and/or supplied by defendants and
`
`- 12 -
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 13 of 23
`
`placed into the stream of commerce in a defective and unreasonably dangerous condition as
`
`designed, taking into account the utility of the product and the risk involved in its use. The
`
`harmful characteristics or consequences of its design outweighed the benefits of the design.
`
`72.
`
`The Durom® Cup hip system implanted in Plaintiff Michael Janisky, as designed,
`
`manufactured, labeled, marketed, distributed, sold and/or supplied by Defendants was defective
`
`and unreasonably dangerous due to its marketing and inadequate warnings or instructions needed
`
`for the reasonably safe use of the device, independently and when coupled with its aggressive
`
`marketing campaign.
`
`73.
`
`The Durom® Cup hip system implanted in Plaintiff Michael Janisky, as designed,
`
`manufactured, labeled, marketed, distributed, sold and/or supplied by Defendants was defective
`
`and unreasonably dangerous because of its marketing due to misbranding, including false and
`
`misleading labeling, independently and when coupled with its aggressive marketing campaign.
`
`74.
`
`Defendants were engaged in the design, manufacture, labeling, marketing,
`
`distribution, dispensing, and sale of the Durom® Cup, and the Durom® Cup hip systems
`
`throughout the United States, including in the State of Arizona and this jurisdiction. Defendants
`
`are also strictly liable to Plaintiffs for the following reasons, including, but not limited to:
`
`a. The Durom® Cup and/or the Durom® Cup hip system was defective, unsafe and
`unreasonably dangerous for its intended and/or foreseeable uses, and was
`defective, unsafe and unreasonably dangerous at the time it was placed into the
`stream of commerce by Defendants and at the time it was prescribed, provided,
`implanted and distributed to Plaintiff;
`
`b. Defendants designed, manufactured, labeled, distributed, provided, dispensed,
`and sold the Durom® Cup and/or the Durom® Cup hip system in such a
`defective and unreasonably dangerous condition that it was likely to cause harm
`to Plaintiff when being used for its intended use;
`
`c. Defendants labeled, distributed, dispensed, and sold the Durom® Cup and/or
`the Durom® Cup hip system in a defective and unreasonably dangerous
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`- 13 -
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 14 of 23
`
`
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`condition due to the product’s design and failure to warn of the dangers
`presented by it;
`
`d. Defendants’ failure to warn of the dangers, rendered the Durom® Cup and/or
`the Durom® Cup hip system extremely hazardous and potentially lethal;
`
`e. The instructions for use and surgical technique instructions were inadequate;
`
`f. Defendants failed to provide timely and adequate warnings or instructions after
`it knew of the risk of injury;
`
`g. Defendants failed to advise patients like Michael Janisky that monitoring of the
`cup was necessary to avoid a long and painful period, where the device failure
`would go undetected as it did here;
`
`h. Defendants knew that Plaintiff would use the Durom® Cup and the Durom®
`Cup hip system without inspection for defects therein;
`
`i. Defendants expected and knew that the Durom® Cup and the Durom® Cup hip
`system would reach Plaintiff, and was in fact received by Plaintiff, without
`change in the condition in which it was first manufactured, distributed,
`provided, prescribed, dispensed and sold; and
`
`j. The said products failed to perform as safely as an ordinary consumer would
`expect when used in a reasonably foreseeable manner.
`
`
`
`
`
`75.
`
`Plaintiff was a foreseeable user and used the Durom® Cup and the Durom® Cup hip
`
`system in their intended manner, and Plaintiff suffered serious harm because of said use.
`
`76.
`
`As the proximate cause and legal result of the defective condition of the Durom®
`
`18
`
`Cup and/or the Durom® Cup hip system and a failure to warn or inadequate warnings, Plaintiff
`
`has been injured, suffered illness and was damaged physically, emotionally and economically;
`
`has required health care and treatment; and has incurred the costs and expense of such health care
`
`and treatment as a direct and indirect result of his implant.
`
`77.
`
`Defendants actually knew of the defective nature of the Durom® Cup and the
`
`Durom® Cup hip system but continued to design, manufacture, label, distribute, dispense, and sell
`
`the Durom® Cup and the Durom® Cup hip system in order to maximize sales and profits at the
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`- 14 -
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 15 of 23
`
`expense of the public health and safety, in conscious disregard of the foreseeable harm. The
`
`defective manner of the Durom® Cup and the Durom® Cup hip system is a contributing cause of
`
`Plaintiffs’ injuries and Plaintiffs’ economic and non-economic loss.
`
`78.
`
`As a direct and proximate result of Defendants’ conduct Plaintiffs are entitled to an
`
`award of compensatory damages.
`
`79.
`
`Defendants’ conduct is attended by circumstances of intentional concealment of
`
`material facts, malice, and willful, wanton and reckless conduct exhibiting disregard for the safety
`
`of others, entitling the plaintiffs to all other damages recoverable under Arizona law.
`
`SECOND CAUSE OF ACTION
`NEGLIGENCE
`
`The allegations contained in all prior paragraphs are incorporated herein by
`
`80.
`
`reference.
`
`81.
`
`Defendants had and continue to have a duty to exercise reasonable care in the
`
`design, testing, manufacture, sale, labeling, distribution, marketing and sale, of said hip implants
`
`into the stream of commerce, including a duty to assure that the product did not cause users to
`
`suffer from unreasonably dangerous side effects.
`
`82.
`
`Defendants violated this standard of care and failed to exercise due care.
`
`Defendants did so by committing acts and omissions that they knew or should have known were
`
`reckless, careless, and done without taking reasonable care and includes, but not limited to, the
`
`following:
`
`a. By negligently and carelessly designing, manufacturing, testing, labeling,
`distributing, marketing, examining, selling, dispensing, and/or preparing said
`implants in such a manner that they were likely to injure Plaintiff;
`
`b. By negligently and carelessly designing, manufacturing, testing, labeling,
`distributing, marketing, examining, selling, dispensing, and/or preparing said
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`- 15 -
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 16 of 23
`
`
`
`
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`implants such that the products were unsafe when they reached the hands of the
`consuming public, including Plaintiff Michael Janisky;
`
`c. By negligently and carelessly designing, manufacturing, testing, labeling,
`distributing, marketing, examining, selling, dispensing, and/or preparing said
`implants prior to placing the same into the general stream of commerce; and,
`
`d. Were otherwise negligent as may be shown in discovery or at the trial of this
`matter.
`
`83.
`
`As a proximate cause and legal result of the defective condition of the said implant
`
`system; a failure to warn or adequately warn; and otherwise negligent acts and omissions of
`
`Defendants, that they knew or should have known about, Plaintiff Michael Janisky has been
`
`injured and damaged physically, emotionally and economically; has required health care and
`
`treatment; and has incurred the costs and expense of such health care and treatment as a direct
`
`and indirect result of the defective hip implants.
`
`84.
`
`As a direct and proximate result of the negligence of Defendants, Plaintiff Michael
`
`Janisky was injured and is entitled to an award of compensatory damages as stated herein.
`
`85.
`
`86.
`
`Defendants are liable to Plaintiffs for their negligence.
`
`Upon information and belief, Defendants’ negligent conduct is attended by
`
`circumstances of intentional concealment of material facts, malice, willful wanton and reckless
`
`conduct exhibiting disregard for the safety of others.
`
`THIRD CAUSE OF ACTION
`NEGLIGENT MISREPRESENTATION AND FRAUD
`
`87.
`
`The allegations contained in all prior paragraphs are incorporated herein by
`
`reference.
`
`88.
`
`Defendants fraudulently, intentionally and/or negligently misrepresented to
`
`Plaintiff Michael Janisky, his surgeon, and the orthopedic surgery community, the safety and
`
`effectiveness of the Durom® Cup and the Durom® Cup hip system and/or fraudulently,
`
`- 16 -
`
`
`
`Case 3:20-cv-08310-DLR Document 1 Filed 11/23/20 Page 17 of 23
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`intentionally or negligently concealed material, adverse information regarding the safety and
`
`effectiveness of that system.
`
`89.
`
`90.
`
`Defendants knew or should have known that these representations were false.
`
`Defendants made representations and/or actively concealed from Plaintiff Michael
`
`Janisky, his sur